Cargando…

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

BACKGROUND: A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906401/ https://www.ncbi.nlm.nih.gov/pubmed/32220112 http://dx.doi.org/10.1111/jth.14817

Ejemplares similares

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”
por: Coto‐Hernández, Rubén, et al.
Publicado: (2020)

Anticoagulation Options for Coronavirus Disease 2019 (COVID-19)-Induced Coagulopathy
por: Turshudzhyan, Alla
Publicado: (2020)

Coronavirus Disease 2019–Associated Coagulopathy
por: Lippi, Giuseppe, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Coagulopathy
por: Seo, Jun-Won, et al.
Publicado: (2022)

Focus on coronavirus disease 2019 associated coagulopathy
por: Yang, Xiang-Hong, et al.
Publicado: (2020)

Coagulopathy in elderly patients with coronavirus disease 2019
por: Yuan, Xueting, et al.
Publicado: (2020)

Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin
por: Yethindra, Vityala, et al.
Publicado: (2020)

Time Course of Coagulopathy Evaluated with Rotational Thromboelastometry in Patients with Severe Coronavirus Disease 2019
por: Yagi, Takeshi, et al.
Publicado: (2022)

Platelet activation and coronavirus disease 2019 mortality: Insights from coagulopathy, antiplatelet therapy and inflammation()
por: Philippe, Aurélien, et al.
Publicado: (2023)

Dermatologists’ Role in the Diagnosis and Management of Coronavirus Disease 2019 Coagulopathy
por: Shah, Payal, et al.
Publicado: (2020)

Coagulopathy in COVID-19 and anticoagulation clinical trials
por: Zhang, Heng, et al.
Publicado: (2022)

Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial
por: Blondon, Marc, et al.
Publicado: (2022)

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021)

Covid-19-induced coagulopathy and observed benefits with anticoagulation
por: Karimzadeh, Sedighe, et al.
Publicado: (2020)

COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation
por: Miesbach, Wolfgang, et al.
Publicado: (2020)

COVID-19 Coagulopathy: Current knowledge and guidelines on anticoagulation
por: Salabei, Joshua K, et al.
Publicado: (2021)

Monitoring of COVID-19-Associated Coagulopathy and Anticoagulation with Thromboelastometry
por: Katz, Daniel, et al.
Publicado: (2021)

Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients
por: Ahmed, Syed Imran, et al.
Publicado: (2020)

Early intubation and decreased in-hospital mortality in patients with coronavirus disease 2019
por: Yamamoto, Ryo, et al.
Publicado: (2022)

Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis
por: Aribawa, I. Gusti Ngurah Mahaalit, et al.
Publicado: (2021)

Coronavirus Disease 2019–Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management
por: Ortega‐Paz, Luis, et al.
Publicado: (2021)

Systemic Coagulopathy in Hospitalized Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)

The unique landscape of coronavirus disease 2019 coagulopathy and imminent bleedings at unusual sites: Pathophysiology matters
por: Paschou, Eleni, et al.
Publicado: (2022)

Anticoagulation and In-Hospital Mortality From Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Moonla, Chatphatai, et al.
Publicado: (2021)

Comparison of the Performance of 24 Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Assays in the Diagnosis of Coronavirus Disease 2019 Patients
por: Wu, Shiji, et al.
Publicado: (2022)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Prealbumin as a Predictor of Prognosis in Patients With Coronavirus Disease 2019
por: Luo, Ying, et al.
Publicado: (2020)

Coronavirus-induced coagulopathy during the course of disease
por: Friedrich, Marie Sophie, et al.
Publicado: (2020)

Coagulopathy: Another side effect of coronavirus infection
por: Sadoughi, Fatemeh, et al.
Publicado: (2021)

Response to Correspondence: Baricitinib: Impact on Coronavirus Disease 2019 (COVID-19) Coagulopathy? Jorgensen et al
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Circulating Extracellular Vesicle Levels in Patients with Coronavirus Disease 2019 Coagulopathy: A Prospective Cohort Study
por: Iwasaki, Yudai, et al.
Publicado: (2023)

Therapeutic anticoagulation using heparin in early phase severe coronavirus disease 2019: A retrospective study
por: Takayama, Wataru, et al.
Publicado: (2022)

Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
por: Salazar, Eric, et al.
Publicado: (2020)

Early coagulopathy in severe iron poisoning
por: Tenenbein, Milton, et al.
Publicado: (1988)

COVID-19-Associated Coagulopathy: A Case Report of Thrombosis despite Therapeutic Anticoagulation
por: Hussain, Habiba, et al.
Publicado: (2020)

Endothelial Dysfunction Is Associated with Mortality and Severity of Coagulopathy in Patients with Sepsis and Disseminated Intravascular Coagulation
por: Walborn, Amanda, et al.
Publicado: (2019)

Lupus anticoagulant-hypoprothrombinemia syndrome with severe bleeding diathesis after coronavirus disease 2019: a case report
por: Brblić, Tomislav, et al.
Publicado: (2022)

Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Favorable Outcomes of Anticoagulation With Unfractioned Heparin in Sepsis-Induced Coagulopathy: A Retrospective Analysis of MIMIC-III Database
por: Peng, Jiang-Chen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9v4i241i9g8vtnfe7svgjplqlh